• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There are few data on how does medication for adhd work long-term exposure may affect a pregnant fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological disorders like hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge that further high-quality research is needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication should consider the benefits of taking it against the possible risks for the baby. Physicians don't have the data to give clear advice however they can provide information on the risks and benefits to assist pregnant women to make informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications during early pregnancy did not face a significantly higher risk of fetal cardiac malformations or major birth defects that are structural. Researchers used a vast population-based study of case-control to evaluate the incidence of major structural birth defects in infants born to mothers who took stimulants during the early stages of pregnancy, and those who did not. Pediatric cardiologists and clinical geneticists examined the cases to ensure correct case classification and to limit the possibility of bias.

However, the study had its limitations. In particular, they were not able to differentiate the effects of the medication from those of the disorder that is underlying. That limitation makes it difficult to know whether the small associations observed in the exposed groups are due to medication use or the confounding effect of comorbidities. The researchers also did not examine long-term outcomes for offspring.

The study did find that infants whose mothers took ADHD medications during pregnancy were at slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or cut back on their medications prior to or during pregnancy. This was due to central nervous system disorders, and the higher risk of admission did not appear to be affected by the type of stimulant medications were used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy were also at an increased risk of having a caesarean birth or having a baby born with an low Apgar score (less than 7). These increases appear to be independent of the type of medication taken during pregnancy.

Researchers suggest that the small risks associated with the use ADHD medication during pregnancies in the early stages may be offset by the more beneficial outcomes for both mother and baby from continuing treatment for the woman's condition. Physicians should discuss this with their patients and, when possible, assist them in developing strategies for improving their coping skills that may minimize the effects of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and treated with medication, the issue of whether to keep or stop treatment during pregnancy is a question that more and more physicians confront. These decisions are frequently made without clear and authoritative evidence. Instead, physicians must weigh their own knowledge, the experience of other doctors, and the research that has been conducted on the subject.

The issue of possible risks to the infant can be difficult to determine. The research on this subject is based on observations rather than controlled studies, and a lot of the results are in conflict. In addition, most studies limit their analysis to live births, which could undervalue the serious teratogenic effects that can doctors prescribe adhd medication (look at this website) cause abortion or termination of the pregnancy. The study that is discussed in this journal club addresses these shortcomings by examining data on both live and deceased births.

The conclusion The conclusion: While some studies have shown a positive association between strattera adhd medication medications and the risk of certain birth defects, others have found no such relationship and the majority of studies have a neutral or slightly negative effect. In the end, a careful risk/benefit assessment must be done in each case.

For a lot of women with ADHD, the decision to discontinue medication is difficult if not impossible. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of isolation. Furthermore, a loss of medication may affect the ability to complete jobs and drive safely that are crucial aspects of daily life for a lot of people with ADHD.

She suggests that women who aren't sure whether to continue taking medication or stop it due to their pregnancy should educate family members, coworkers, and acquaintances about the condition, its impact on daily functioning and the benefits of keeping the current treatment. It can also help women feel more confident in her decision. Certain medications can pass through the placenta. If a patient decides to stop taking her ADHD medication while breastfeeding, it is crucial to be aware that the drug could be transferred to the infant.

Risk of Birth Defects

As the use of best adhd medication for adults uk drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns over the impact that these drugs could have on fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of knowledge on this subject. Utilizing two huge data sets researchers were able examine more than 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. Although the risk overall remains low, the researchers discovered that the first-trimester exposure to ADHD medications was linked to an increased risk of certain heart defects, such as ventriculoseptal defect (VSD).

The authors of the study didn't discover any connection between early medication usage and other congenital anomalies, such as facial deformities or club feet. The results are in line with previous studies that have shown the existence of a slight, but significant increase in the number of cardiac malformations among women who started taking ADHD medication before the birth of their child. This risk increased in the latter half of pregnancy, as many women are forced to stop taking their medication.

Women who were taking ADHD medication during the first trimester were more likely to require a caesarean delivery, have an insufficient Apgar after delivery, and had a baby that required breathing assistance at birth. The researchers of the study were not able to remove bias in selection since they limited their study to women who did not have any other medical conditions that might have contributed to the findings.

Researchers hope that their research will help doctors when they see pregnant women. They suggest that although the discussion of the risks and benefits is crucial, the decision to stop or continue medication should be based on the woman's needs and the severity of her ADHD symptoms.

The authors caution that, while stopping the medication is an option to think about, it isn't recommended because of the high incidence of depression and other mental problems in women who are expecting or recently gave birth. Furthermore, research suggests that women who choose to stop taking their medication are more likely to have difficulties adapting to life without them after the birth of their baby.

Nursing

The responsibilities of being a new mother can be overwhelming. Women who suffer from adhd and anxiety medication are often faced with a number of difficulties when they have to manage their symptoms, attend doctor appointments and prepare for the birth of a baby and adjust to new routines. Therefore, many women elect to continue taking their ADHD medication throughout the pregnancy.

The risk to breastfeeding infant is minimal because the majority of stimulant medication passes through breast milk at a low level. However, the amount of medication exposure to the newborn can vary depending on dosage, frequency it is taken and the time of the day it is administered. In addition, various medications enter the baby’s system through the gastrointestinal tract or breast milk. The impact of these medications on the health of a newborn is not completely understood.

Because of the lack of evidence, some doctors may recommend stopping stimulant medications during the course of pregnancy. This is a complicated decision for the patient, who must weigh the benefit of continuing her medication with the potential dangers to the embryo. Until more information is available, doctors should ask all pregnant patients about their experience with ADHD and whether they plan or are taking to take medication during the perinatal period.

A increasing number of studies have shown that women can continue their ADHD medication during pregnancy and breastfeeding. In response, a rising number of patients are choosing to continue their medication. They have concluded through consultation with their doctors, that the benefits of continuing their current medication far outweigh any possible risks.

Women with ADHD who are planning to nurse should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor, and the pros and cons of continuing treatment. This includes non amphetamine adhd medication-pharmacological methods. Psychoeducation is also required to help pregnant women suffering from ADHD understand their symptoms and the underlying disorder, learn about available treatments and to reinforce existing strategies for coping. This should be a multidisciplinary approach with the GPs, obstetricians, and psychiatry. Pregnancy counseling should consist of a discussion of a treatment plan for the mother as well as the child, and monitoring for indicators of deterioration, and, if needed, adjustments to the medication regimen.